123 related articles for article (PubMed ID: 31746087)
61. Phase I and pharmacokinetic study of TZT-1027, a novel synthetic dolastatin 10 derivative, administered as a 1-hour intravenous infusion every 3 weeks in patients with advanced refractory cancer.
Schöffski P; Thate B; Beutel G; Bolte O; Otto D; Hofmann M; Ganser A; Jenner A; Cheverton P; Wanders J; Oguma T; Atsumi R; Satomi M
Ann Oncol; 2004 Apr; 15(4):671-9. PubMed ID: 15033678
[TBL] [Abstract][Full Text] [Related]
62. Valganciclovir-induced leukopenia in liver transplant recipients: influence of concomitant use of mycophenolate mofetil.
Molina Perez E; Fernández Castroagudín J; Seijo Ríos S; Mera Calviño J; Tomé Martínez de Rituerto S; Otero Antón E; Bustamante Montalvo M; Varo Perez E
Transplant Proc; 2009 Apr; 41(3):1047-9. PubMed ID: 19376423
[TBL] [Abstract][Full Text] [Related]
63. Impact of complete blood count sampling time change on white blood cell and absolute neutrophil count values in clozapine recipients.
McKee JR; Wall T; Owensby J
Clin Schizophr Relat Psychoses; 2011 Apr; 5(1):26-32. PubMed ID: 21459736
[TBL] [Abstract][Full Text] [Related]
64. Hematologic monitoring in children with epilepsy treated with carbamazepine.
Evans OB; Gay H; Swisher A; Parks B
J Child Neurol; 1989 Oct; 4(4):286-90. PubMed ID: 2794381
[TBL] [Abstract][Full Text] [Related]
65. Meta-analysis of neutropenia or leukopenia as a prognostic factor in patients with malignant disease undergoing chemotherapy.
Shitara K; Matsuo K; Oze I; Mizota A; Kondo C; Nomura M; Yokota T; Takahari D; Ura T; Muro K
Cancer Chemother Pharmacol; 2011 Aug; 68(2):301-7. PubMed ID: 20960191
[TBL] [Abstract][Full Text] [Related]
66. Clinical trial of recombinant granulocyte colony-stimulating factor for chemotherapy-induced neutropenia patients with oral cancer.
Iwase M; Yoshiya M; Kakuta S; Nagumo M
J Oral Maxillofac Surg; 1997 Aug; 55(8):836-40; discussion 841. PubMed ID: 9251612
[TBL] [Abstract][Full Text] [Related]
67. Psychometric Properties of the Functional Assessment of Cancer Therapy-Neutropenia in Asian Cancer Patients With Chemotherapy-Induced Neutropenia.
Wang XJ; Wong CM; Chan A
J Pain Symptom Manage; 2016 Sep; 52(3):428-36. PubMed ID: 27392885
[TBL] [Abstract][Full Text] [Related]
68. A Comparison Study Between Point-of-Care Testing Systems and Central Laboratory for Determining Blood Glucose in Venous Blood.
Wei H; Lan F; He Q; Li H; Zhang F; Qin X; Li S
J Clin Lab Anal; 2017 May; 31(3):. PubMed ID: 27558572
[TBL] [Abstract][Full Text] [Related]
69. Implementation of point-of-care testing in a pediatric healthcare setting.
Patel K; Suh-Lailam BB
Crit Rev Clin Lab Sci; 2019 Jun; 56(4):239-246. PubMed ID: 30973797
[TBL] [Abstract][Full Text] [Related]
70. Evaluation of PIMA point-of-care CD4 testing in a large UK HIV service.
Herbert S; Edwards S; Carrick G; Copas A; Sandford C; Amphlett M; Benn P
Sex Transm Infect; 2012 Oct; 88(6):413-7. PubMed ID: 22544309
[TBL] [Abstract][Full Text] [Related]
71. Predictive value of monocytes and lymphocytes for short-term neutrophil changes in chemotherapy-induced severe neutropenia in solid tumors.
Zheng B; Huang Z; Huang Y; Hong L; Li J; Wu J
Support Care Cancer; 2020 Mar; 28(3):1289-1294. PubMed ID: 31240465
[TBL] [Abstract][Full Text] [Related]
72. Decreased sensitivity of the automatic white precursor cell channel (WPC) for blast flagging in patients with leukopenia.
Lee N; Jun JH; Lee DS
Clin Biochem; 2016 Jun; 49(9):675-681. PubMed ID: 26800779
[TBL] [Abstract][Full Text] [Related]
73. Neutrophil count in African Americans: lowering the target cutoff to initiate or resume chemotherapy?
Hsieh MM; Tisdale JF; Rodgers GP; Young NS; Trimble EL; Little RF
J Clin Oncol; 2010 Apr; 28(10):1633-7. PubMed ID: 20194862
[No Abstract] [Full Text] [Related]
74. Benign familial leukopenia and neutropenia in different ethnic groups.
Shoenfeld Y; Alkan ML; Asaly A; Carmeli Y; Katz M
Eur J Haematol; 1988 Sep; 41(3):273-7. PubMed ID: 3181399
[TBL] [Abstract][Full Text] [Related]
75. Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients.
Oude Nijhuis CSM; Vellenga E; Daenen SMGJ; van der Graaf WTA; Gietema JA; Groen HJM; Kamps WA; de Bont ESJM
Intensive Care Med; 2003 Dec; 29(12):2157-2161. PubMed ID: 14569424
[TBL] [Abstract][Full Text] [Related]
76. [Basic Evaluation of Microsemi LC-767CRP as POCT Model for Simultaneous Measurement of CBC and CRP].
Inaba T; Ikeda M; Saitoh K; Yuasa S; Mishima N; Ogura K; Oku N; Kodama M; Fujitomo Y; Nakanishi M; Fujita N
Rinsho Byori; 2016 Feb; 64(2):152-6. PubMed ID: 27311278
[TBL] [Abstract][Full Text] [Related]
77. Model-based prediction of myelosuppression and recovery based on frequent neutrophil monitoring.
Netterberg I; Nielsen EI; Friberg LE; Karlsson MO
Cancer Chemother Pharmacol; 2017 Aug; 80(2):343-353. PubMed ID: 28656382
[TBL] [Abstract][Full Text] [Related]
78. [Hematologic findings in leukopenia induced by cytostatics and the autologous bone marrow reinfusion (after 10 years of clinical use)].
Karrer K; Mannheimer E
Wien Z Inn Med; 1973; 54(2):51-68. PubMed ID: 4588076
[No Abstract] [Full Text] [Related]
79. Incidence, treatment, and consequences of chemotherapy-induced febrile neutropenia in the inpatient and outpatient settings.
Weycker D; Barron R; Kartashov A; Legg J; Lyman GH
J Oncol Pharm Pract; 2014 Jun; 20(3):190-8. PubMed ID: 23824496
[TBL] [Abstract][Full Text] [Related]
80. Combined utility of white blood cell count and blood glucose for predicting in-hospital outcomes in acute ischemic stroke.
You S; Ou Z; Zhang W; Zheng D; Zhong C; Dong X; Qiu C; Lu T; Cao Y; Liu CF
J Neuroinflammation; 2019 Feb; 16(1):37. PubMed ID: 30764852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
